SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,152.86 -417.49
( -0.55%)

Global Indices

Nasdaq

53,087.25 299.37
(0.57%)

Dow Jones

7,688.45 35.98
(0.47%)

Hang Seng

64,337.38 11.74
(0.02%)

Nikkei 225

10,831.87 75.42
(0.70%)

Forex

USD-INR

94.95 -0.29
(-0.30%)

EUR-INR

110.11 -0.38
(-0.35%)

GBP-INR

128.48 -0.52
(-0.40%)

JPY-INR

0.59 0.00
(-0.47%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dynavision Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

517238

INE083E01010

88.9541667

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

10.63

92.93

EPS(TTM)

Face Value()

Div & Yield %

22.76

Back

Glaxosmithkline Pharmaceuticals consolidated net profit rises 15.69% in the June 2026 quarter

Aug 03,2026

Net profit of Glaxosmithkline Pharmaceuticals rose 15.69% to Rs 237.18 crore in the quarter ended June 2026 as against Rs 205.01 crore during the previous quarter ended June 2025. Sales rose 16.55% to Rs 938.44 crore in the quarter ended June 2026 as against Rs 805.17 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	938.44	805.17	17
OPM %	31.49	31.20	-
PBDT	338.29	294.50	15
PBT	322.45	278.98	16
NP	237.18	205.01	16

76,152.86 -417.49 ( -0.55%)

53,087.25 299.37 (0.57%)

7,688.45 35.98 (0.47%)

64,337.38 11.74 (0.02%)

10,831.87 75.42 (0.70%)

94.95 -0.29 (-0.30%)

110.11 -0.38 (-0.35%)

128.48 -0.52 (-0.40%)

0.59 0.00 (-0.47%)